Stocktoria
Benitec Biopharma Inc. BNTC
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2012-07-11
Benitec Biopharma Inc. statistics & valuation
Market cap$425.0M
P / B4.4×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating margin | — | — | -25441.3% | -24457.5% | -23044.1% |
| Net margin | — | — | -26082.7% | -24942.5% | -23528.8% |
| FCF margin | — | — | -24017.3% | -21797.3% | -22123.7% |
| Return on assets | -38.1% | -41.7% | -438.2% | -304.8% | -64.9% |
| Return on equity | -39.0% | -46.0% | -9684.2% | -631.8% | -69.4% |
| Current ratio | 54.67 | 10.49 | 0.94 | 1.90 | 15.05 |
| Revenue growth | — | -100.0% | 2.7% | 23.7% | -42.2% |
Source: SEC EDGAR filings · CIK 0001808898 · as of 2025-06-30. Facts from filings plus Stocktoria's own computed scores — not investment advice.